ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

LCAV (MM)

5.37
0.00 (0.00%)
Last Updated: 01:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type
(MM) NASDAQ:LCAV NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 5.37 0 01:00:00

LCA-Vision Announces the Addition of Dr. Jeffrey B. Robin to its Orlando LasikPlus Vision Center

25/05/2005 7:44pm

PR Newswire (US)


(MM) (NASDAQ:LCAV)
Historical Stock Chart


From Aug 2019 to Aug 2024

Click Here for more (MM) Charts.
LCA-Vision Announces the Addition of Dr. Jeffrey B. Robin to its Orlando LasikPlus Vision Center Joining Forces with Dr. Lewis R. Groden to Serve the Growing Central Florida Market CINCINNATI, May 25 /PRNewswire-FirstCall/ -- LCA-Vision Inc. (NASDAQ:LCAV), a leading provider of laser vision correction services under the LasikPlus brand, announced today that Dr. Jeffrey B. Robin has joined the company. Dr. Robin, a board-certified ophthalmologist and internationally recognized authority in the field of refractive surgery, joins forces with Dr. Lewis R. Groden at the company's Orlando LasikPlus vision center as it continues to grow. Dr. Robin has focused exclusively on refractive surgery for the past 10 years. He is a member of numerous medical and ophthalmic professional organizations and has served on several journal and editorial advisory boards. Commenting on Dr. Robin's appointment, Stephen N. Joffe, LCA-Vision's chairman and chief executive officer said, "We are privileged to have Dr. Robin join our Orlando LasikPlus vision center. Dr. Robin is an outstanding, seasoned, and talented ophthalmologist who we believe will play a key role along with Dr. Groden in charting our future growth in central Florida. The combination of these experienced ophthalmologists will help us meet the growing demand for the procedure in the central Florida market. Combined, Dr. Robin and Dr. Groden have performed approximately 65,000 procedures." Laser vision correction is now one of the most frequently performed elective surgical procedure in the United States. The potential patient pool is large, with significant growth potential. Coupling experienced and respected ophthalmologists with advanced technology and a commitment to provide patients with superior services at an affordable price, LCA- Vision/LasikPlus has become one of the leading providers of laser vision correction services in the United States. Forward-Looking Statements This news release contains forward-looking statements that are subject to risks and uncertainties that may cause actual results to differ materially from current expectations. For a discussion of risks and uncertainties we face, please refer to our filings with the Securities and Exchange Commission including, but not limited to, our Forms 10-K and 10-Q. About LCA-Vision Inc./LasikPlus LCA-Vision Inc. is a leading provider of laser vision correction services under the LasikPlus brand. We own and operate 42 LasikPlus fixed-site laser vision correction centers in the United States and a joint venture in Canada. Additional information is available at our corporate websites: http://www.lca-vision.com/ and http://www.lasikplus.com/ . It's Not Just LASIK. It's LasikPlus! For Additional Information Patricia Forsythe V.P. Investor Relations 513-792-5629 DATASOURCE: LCA-Vision Inc. CONTACT: Patricia Forsythe, V.P. Investor Relations of LCA-Vision Inc., +1-513-792-5629, or Web site: http://www.lca-vision.com/ http://www.lasikplus.com/

Copyright

1 Year (MM) Chart

1 Year (MM) Chart

1 Month (MM) Chart

1 Month (MM) Chart